Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer

Study limitation reported by the research below: “Study design is retrospective and hypothesis-generating; no clinical outcomes or treatment response data are included. Findings should not yet guide clinical decision-making.”